News
The transaction brings larsucosterol, an investigational treatment for alcoholic hepatitis, under Bausch Health’s portfolio ...
Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.
Liver disease often develops silently, but certain changes in the skin can act as early warning signs. Dr. Saurabh Sethi, a ...
New research confirms eggs don’t raise cholesterol—saturated fat in breakfast sides does. Experts explain what to eat for a ...
Without efforts to address some causes, including alcohol use and metabolic issues, the researchers warn that cases could ...
CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...
5h
The Hearty Soul on MSNDeficiency in Key Vitamin Linked to Liver DiseaseFatty liver disease is one of the fastest-growing health concerns worldwide, impacting roughly 32% of people worldwide, according to a 2022 systematic review. It is closely tied to rising rates of ...
A new report in “The Lancet” finds liver cancer cases are preventable, with some steps to abide by. A new analysis of ...
MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.
Cholesterol buildup in liver fat droplets directly drives fibrosis in metabolic disease, study finds
Cholesterol plays a vital role in the body, providing structural support to cells and serving as a building block for hormone ...
U.S. drugmaker Madrigal Pharmaceuticals has struck a licensing deal with CSPC Pharmaceutical Group that could be worth more than $2 billion for the Chinese company if it results in a new drug for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results